⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMLX News
Amylyx Pharmaceuticals, Inc. Common Stock
Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation
businesswire.com
AMLX
Form 8-K
sec.gov
AMLX
Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia
businesswire.com
AMLX
Did Amylyx Pharmaceuticals, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
prnewswire.com
AMLX
Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
businesswire.com
AMLX
Form 8-K
sec.gov
AMLX
Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
businesswire.com
AMLX
Form 8-K
sec.gov
AMLX
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
businesswire.com
AMLX
Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences
businesswire.com
AMLX